AFL stock holds near earnings benchmarks as Aflac reports 2025 results

AFL stock is anchored by Aflac Incorporated's 2025 metrics, including $18.3 billion in revenue and $4.3 billion in net earnings, while shares are tracked against a market value reference in the latest available data.

Aflac Incorporated (US0010551028) posted $18.3 billion in revenue for 2025 and $4.3 billion in net earnings, with adjusted EPS of $7.57 and adjusted earnings growth of 19.8% year on year. The company also returned $1.9 billion to shareholders through dividends and buybacks in 2025, according to its 2025 annual report on Aflac investors.

Revenue at $18.3 billion

The 2025 revenue figure of $18.3 billion came alongside $4.3 billion in net earnings, giving the insurer a clear earnings base to measure against its 2026 operating cadence. Adjusted EPS of $7.57 and adjusted earnings growth of 19.8% year on year are the two numbers that matter most in the latest published financial picture.

For investors, the comparison is the point: 19.8% adjusted earnings growth is a sharper signal than a static headline revenue line. The figure shows that earnings expanded faster than the top line, which usually points to operating leverage, underwriting discipline, or both.

Capital returns reached $1.9 billion

Aflac said it returned $1.9 billion to shareholders in 2025 through dividends and repurchases, a sizeable capital-allocation number that sits next to the $4.3 billion net earnings base. The insurer also ended 2025 with adjusted book value per share of $57.11, which gives another dated reference point for balance-sheet and valuation work.

That mix matters because capital returns and book value often frame how insurance earnings are translated into per-share value. A stock can look cheap or expensive only after those two numbers are set against earnings power, and Aflac has both figures clearly visible in its latest annual reporting.

Book value at $57.11

Adjusted book value per share of $57.11 at 31 December 2025 provides a clean historical marker for the stock's capital base. Combined with 2025 adjusted EPS of $7.57, it implies a company that is still producing a meaningful earnings stream relative to its reported equity value.

The company also reported $18.3 billion in revenue for 2025, so the earnings profile is being built on a large and repeatable premium base rather than a one-off event. That is the core reason the shares are often judged on consistency rather than headline growth alone.

Insurance product mix

The product mix still centers on life and supplemental health insurance, which is the operating base behind the 2025 numbers. That model helps explain why revenue of $18.3 billion and net earnings of $4.3 billion can coexist with a relatively steady capital-return policy.

Adjusted earnings of $7.57 per share in 2025 are the most useful per-share metric in that mix because they translate the business into a stock-level measure. Aflac's share story is therefore less about a single catalyst and more about whether the earnings base keeps compounding at a double-digit pace.

Stock level and valuation frame

A dated market price was not available in the search results for this call, so the cleanest valuation anchors are the 2025 reported figures: $18.3 billion revenue, $4.3 billion net earnings, and $57.11 adjusted book value per share. Those three numbers set the frame for any near-term reading of AFL stock.

At 31 December 2025, the company's balance-sheet and earnings data still gave the stock a measurable reference point even without a fresh quote. The important part is that the latest available report provides enough dated evidence to judge the shares against earnings, book value, and capital returns rather than against a slogan.

Company facts

• Company: Aflac Incorporated
• ISIN: US0010551028
• Ticker: NYSE: AFL
• Trading venue: NYSE
• Sector / Industry: Financials / Life and Health Insurance
• Index membership: S&P 500